← Back
Editing: dovecot.index.cache
��bi�b a �o ���� � V�b L Message-ID: <guhvCJDFNsnsle2vedgM1vhcOxhA3J3u3GEuOMB1C0@easywp.com> 4 Subject: Website Form Submission - Event 01 : From: Website Forms <webmail@metamorphglobal.net> � ��b : From: Website Forms <webmail@metamorphglobal.net> M Message-ID: <QWQMjBNfgJBbTMbN2ykHC3ElYjVur59fJu5j8ifKRSg@easywp.com> 4 Subject: Website Form Submission - Event 01 � ��b @ From: "Microsoft Outlook" <webmail@metamorphglobal.net> 0 Subject: Microsoft Outlook Test Message � #��b : From: Website Forms <webmail@metamorphglobal.net> M Message-ID: <2SDxi69lo8u5IuM5Q6CE2idpAo8CJi8OWzuvck1M4kw@easywp.com> 4 Subject: Website Form Submission - Event 01 � |��b : From: Website Forms <webmail@metamorphglobal.net> K Message-ID: <IwXdJetKOxsNMj9O2RZHsPj2oMuLu0gjA7SKEGhAI@easywp.com> 4 Subject: Website Form Submission - Event 01 � ���b : From: Website Forms <webmail@metamorphglobal.net> I Message-ID: <eiyXv1s2etm1xLs3Y0em5CTUUQ1c4UQgwYoSswY@easywp.com> 4 Subject: Website Form Submission - Event 01 � ��b : From: Website Forms <webmail@metamorphglobal.net> M Message-ID: <NIfPDLpbs0hF3QtZHcSBBVHnBKp4tiD6F1krhzfXqEc@easywp.com> 4 Subject: Website Form Submission - Event 01 � �D�b : From: Website Forms <webmail@metamorphglobal.net> M Message-ID: <NZaWwEag3PzycPXTZYhO31R5PgdaGZfofXOe7y2ibK4@easywp.com> 4 Subject: Website Form Submission - Event 01 � '��b @ From: "Microsoft Outlook" <webmail@metamorphglobal.net> 0 Subject: Microsoft Outlook Test Message � S$�b : From: Website Forms <webmail@metamorphglobal.net> J Message-ID: <mC70YAjHLqQ5Pz8PqJSqibLsLNxMMeretFj6sbnQ@easywp.com> 4 Subject: Website Form Submission - Event 01 � �4�b : From: Website Forms <webmail@metamorphglobal.net> L Message-ID: <cOHQrIJVPnt6fOaTCIeiFyZSl8lCEAk7HX18aiKS9U@easywp.com> 4 Subject: Website Form Submission - Event 01 � �[�b : From: Website Forms <webmail@metamorphglobal.net> L Message-ID: <yUtl5v30xMhtchgLgMPJOOGe3ol0IMN67DZQZ1h0jo@easywp.com> 4 Subject: Website Form Submission - Event 01 � u_�b : From: Website Forms <webmail@metamorphglobal.net> M Message-ID: <34CN1itzNjgdo5ln6uwyYBmMkNPlvep4SoKiDJ6i79A@easywp.com> 4 Subject: Website Form Submission - Event 01 � Db�b : From: Website Forms <webmail@metamorphglobal.net> M Message-ID: <IzCvGqv2OzKKncq7z4pb5Q1fBm3CK6Jq86j12RqLo9E@easywp.com> 4 Subject: Website Form Submission - Event 01 � bA�b : From: Website Forms <webmail@metamorphglobal.net> M Message-ID: <u1OMwztvYfYhz7WQciAxyghruiiX1LnTuGvth99RohU@easywp.com> 4 Subject: Website Form Submission - Event 01 � Ǧ�b : From: Website Forms <webmail@metamorphglobal.net> M Message-ID: <VgonhHzyGPognKG2G2s6R0B4VzuhvDjgavxNdy268uY@easywp.com> 4 Subject: Website Form Submission - Event 01 ���b : From: Website Forms <webmail@metamorphglobal.net> M Message-ID: <IuSlqLsa2XuYNmdcdZKVeWlPZDm0J068KJUhFtumghs@easywp.com> O Subject: STATISTICS FOR QUALITY CONTROL AND QUALITY ASSURANCE PRACTICE ���b : From: Website Forms <webmail@metamorphglobal.net> M Message-ID: <CJHvB4nJ2pRPz0aN0zRYLoHQUlie4ySa9jxe2wqJYRQ@easywp.com> R Subject: EU-STATISTICS FOR QUALITY CONTROL AND QUALITY ASSURANCE PRACTICE lf�b : From: Website Forms <webmail@metamorphglobal.net> M Message-ID: <TwoQyeXFX6wx7azM5lcWh3jSZowvkJgWFbwVgijG6XU@easywp.com> O Subject: STATISTICS FOR QUALITY CONTROL AND QUALITY ASSURANCE PRACTICE �b�b : From: Website Forms <webmail@metamorphglobal.net> M Message-ID: <XJsDgAi4MTTauv8WiWiRUww2DiVCNJZzAXibtSCAAZY@easywp.com> O Subject: STATISTICS FOR QUALITY CONTROL AND QUALITY ASSURANCE PRACTICE �>�b : From: Website Forms <webmail@metamorphglobal.net> K Message-ID: <Yo7xkR474Ypm1hDggt96WIVZBSRkf7RKOp9qmKC0I@easywp.com> O Subject: STATISTICS FOR QUALITY CONTROL AND QUALITY ASSURANCE PRACTICE 1�b : From: Website Forms <webmail@metamorphglobal.net> K Message-ID: <kr22ux9CGbLvMFYUgpt2iwgBc08hmO8GyZiheLHmk@easywp.com> O Subject: STATISTICS FOR QUALITY CONTROL AND QUALITY ASSURANCE PRACTICE C�b M From: Mail Delivery System <Mailer-Daemon@premium80.web-hosting.com> B Message-Id: <E1nyDzv-00G84J-8U@premium80.web-hosting.com> C Subject: Mail delivery failed: returning message to sender �K�b : From: Website Forms <webmail@metamorphglobal.net> K Message-ID: <n3YUGfr9imIet5rj5daKL6pNvneElCHURL4xz0kno@easywp.com> O Subject: STATISTICS FOR QUALITY CONTROL AND QUALITY ASSURANCE PRACTICE L�b : From: Website Forms <webmail@metamorphglobal.net> L Message-ID: <IaV7Wgjq2JPATVBmPw01vJXLCGNbpd9RLy7NkvDZhc@easywp.com> O Subject: STATISTICS FOR QUALITY CONTROL AND QUALITY ASSURANCE PRACTICE � aL�b : From: Website Forms <webmail@metamorphglobal.net> H Message-ID: <y5E6NnqUkmeSxkAPaJqr7UbwAzt2nDuGGaTB7c@easywp.com> O Subject: STATISTICS FOR QUALITY CONTROL AND QUALITY ASSURANCE PRACTICE zL�b : From: Website Forms <webmail@metamorphglobal.net> L Message-ID: <cQpXAFv8MARNLyFNpG5kdBfn7zGyAiLF9p0BRPPju8@easywp.com> O Subject: STATISTICS FOR QUALITY CONTROL AND QUALITY ASSURANCE PRACTICE �L�b : From: Website Forms <webmail@metamorphglobal.net> M Message-ID: <ExbCuYharwwySHWxTIqhGBRMeplFwYqjtNvZy0JWdvY@easywp.com> O Subject: STATISTICS FOR QUALITY CONTROL AND QUALITY ASSURANCE PRACTICE M�b : From: Website Forms <webmail@metamorphglobal.net> L Message-ID: <4mZ3YLef8dvq5X9sYIfzx7Cv9nuKSVLYqEe3CCLpgA@easywp.com> O Subject: STATISTICS FOR QUALITY CONTROL AND QUALITY ASSURANCE PRACTICE gM�b : From: Website Forms <webmail@metamorphglobal.net> L Message-ID: <SAqRUT6ImMhaVNTim8r8bDujRfzggnN7TNVcQqk5Ek@easywp.com> O Subject: STATISTICS FOR QUALITY CONTROL AND QUALITY ASSURANCE PRACTICE �M�b : From: Website Forms <webmail@metamorphglobal.net> L Message-ID: <vwo4UYKQIBSjcOFIio7lqMQaNXZZ0BqaEZlXgjTQuE@easywp.com> O Subject: STATISTICS FOR QUALITY CONTROL AND QUALITY ASSURANCE PRACTICE �N�b : From: Website Forms <webmail@metamorphglobal.net> L Message-ID: <0aQgZmYqLpeQFFmWk18j3w6uBEdlcGUYeoCUElE9AE@easywp.com> O Subject: STATISTICS FOR QUALITY CONTROL AND QUALITY ASSURANCE PRACTICE 2P�b : From: Website Forms <webmail@metamorphglobal.net> K Message-ID: <6dajnKd9Ueqf6r1Hi3ywDdJpUtqPJX8Qd7ITgqE1s@easywp.com> O Subject: STATISTICS FOR QUALITY CONTROL AND QUALITY ASSURANCE PRACTICE pQ�b : From: Website Forms <webmail@metamorphglobal.net> K Message-ID: <ZMZUsC5KOEKgiRghDMej3zkNyfrkuEYXDGNVS1fyA@easywp.com> O Subject: STATISTICS FOR QUALITY CONTROL AND QUALITY ASSURANCE PRACTICE �Q�b : From: Website Forms <webmail@metamorphglobal.net> K Message-ID: <gRl7pxdEnyX2EIHTYYG4WJhspMzmvLZayFC5Bh9O8@easywp.com> O Subject: STATISTICS FOR QUALITY CONTROL AND QUALITY ASSURANCE PRACTICE �Q�b : From: Website Forms <webmail@metamorphglobal.net> L Message-ID: <WSncBvdVzjd0g8bq8qRZnYgSjk40i6WClpDtX9qWCA@easywp.com> O Subject: STATISTICS FOR QUALITY CONTROL AND QUALITY ASSURANCE PRACTICE R�b : From: Website Forms <webmail@metamorphglobal.net> M Message-ID: <i6QqJ8CzUGOuzGiWx9pylBeJMbbTwyD7L4uQAtuDSts@easywp.com> O Subject: STATISTICS FOR QUALITY CONTROL AND QUALITY ASSURANCE PRACTICE �\�b : From: Website Forms <webmail@metamorphglobal.net> J Message-ID: <glfNqtEKIw4LJdErHPm8gXIh8h6tNgKqQ3qFKUWE@easywp.com> O Subject: STATISTICS FOR QUALITY CONTROL AND QUALITY ASSURANCE PRACTICE b�b : From: Website Forms <webmail@metamorphglobal.net> J Message-ID: <mYaJaBxR1MZMBZNV3YNImelcZ83VkL4DWChrGsSA@easywp.com> R Subject: EU-STATISTICS FOR QUALITY CONTROL AND QUALITY ASSURANCE PRACTICE �e�b : From: Website Forms <webmail@metamorphglobal.net> M Message-ID: <Xxrkhl82iH9SDUqL2wg5wqRB5mvBwhffCPdCBBnMz2Y@easywp.com> O Subject: STATISTICS FOR QUALITY CONTROL AND QUALITY ASSURANCE PRACTICE 3q�b : From: Website Forms <webmail@metamorphglobal.net> L Message-ID: <RIECixhf5VY9IQ00O06VEsOEaAiochvVafzwSCKPvI@easywp.com> O Subject: STATISTICS FOR QUALITY CONTROL AND QUALITY ASSURANCE PRACTICE �)�b : From: Website Forms <webmail@metamorphglobal.net> J Message-ID: <9q1dFQuDlw82wgpichSqQyk6u8XtqsQYnJNB16B8@easywp.com> O Subject: STATISTICS FOR QUALITY CONTROL AND QUALITY ASSURANCE PRACTICE �b : From: Website Forms <webmail@metamorphglobal.net> L Message-ID: <1GzvqOU2kQHux4BWMOy1XyqwlYHm7kVAGxtoX3LbKQ@easywp.com> O Subject: STATISTICS FOR QUALITY CONTROL AND QUALITY ASSURANCE PRACTICE yV�b : From: Website Forms <webmail@metamorphglobal.net> L Message-ID: <rhGlQoQ30SLwlS6jKgHUEk2Iu0bXrY6BYFWCTRzxQk@easywp.com> O Subject: STATISTICS FOR QUALITY CONTROL AND QUALITY ASSURANCE PRACTICE WG�b : From: Website Forms <webmail@metamorphglobal.net> M Message-ID: <ubApknpl06azH2zeCvueKPWp6DDTMmfNNWR5swfuHaw@easywp.com> O Subject: STATISTICS FOR QUALITY CONTROL AND QUALITY ASSURANCE PRACTICE �P�b M From: Mail Delivery System <Mailer-Daemon@premium80.web-hosting.com> B Message-Id: <E1o0lWB-002bI2-Jm@premium80.web-hosting.com> C Subject: Mail delivery failed: returning message to sender 匰b M From: Mail Delivery System <Mailer-Daemon@premium80.web-hosting.com> B Message-Id: <E1o3Iyj-009gYb-AJ@premium80.web-hosting.com> C Subject: Mail delivery failed: returning message to sender � ���b @ From: "Microsoft Outlook" <webmail@metamorphglobal.net> 0 Subject: Microsoft Outlook Test Message , U��b : From: Website Forms <webmail@metamorphglobal.net> M Message-ID: <9qW4Ogn4thnDN6JIElWpI4eQnpJhAqywaWjNgncdxjs@easywp.com> u Subject: =?UTF-8?Q?Changes_and_Complementation_in_ICH_Q2(R2)_=E2=80=93_Validation_of_Analytical_Procedures?= �߹b M From: Mail Delivery System <Mailer-Daemon@premium80.web-hosting.com> B Message-Id: <E1o5rw3-00AcZM-L1@premium80.web-hosting.com> C Subject: Mail delivery failed: returning message to sender ��b M From: Mail Delivery System <Mailer-Daemon@premium80.web-hosting.com> B Message-Id: <E1o8PMk-000ugL-Fi@premium80.web-hosting.com> C Subject: Mail delivery failed: returning message to sender 3Y�b M From: Mail Delivery System <Mailer-Daemon@premium80.web-hosting.com> B Message-Id: <E1oAwuB-00CEal-E7@premium80.web-hosting.com> C Subject: Mail delivery failed: returning message to sender ( :��b : From: Website Forms <webmail@metamorphglobal.net> L Message-ID: <3kMFtUZm1dkCRHDp88nJpYiYVXNvPu16BxbBtnK51k@easywp.com> u Subject: =?UTF-8?Q?Changes_and_Complementation_in_ICH_Q2(R2)_=E2=80=93_Validation_of_Analytical_Procedures?= , e��b : From: Website Forms <webmail@metamorphglobal.net> M Message-ID: <dCxHaa0r7WMDbdIzAnk9CIFvl6Qg3SlUDNp7Fvl87j4@easywp.com> u Subject: =?UTF-8?Q?Changes_and_Complementation_in_ICH_Q2(R2)_=E2=80=93_Validation_of_Analytical_Procedures?= n�b M From: Mail Delivery System <Mailer-Daemon@premium80.web-hosting.com> B Message-Id: <E1oBQcg-006FjC-85@premium80.web-hosting.com> C Subject: Mail delivery failed: returning message to sender ( �-�b : From: Website Forms <webmail@metamorphglobal.net> L Message-ID: <ynlzTXmdNxGTC5jmhjls0H4gQ1I52utTCVuKCnG3fk@easywp.com> u Subject: =?UTF-8?Q?Changes_and_Complementation_in_ICH_Q2(R2)_=E2=80=93_Validation_of_Analytical_Procedures?= , PC�b : From: Website Forms <webmail@metamorphglobal.net> M Message-ID: <gnhO3JDqIcmjFT6JzrDpB3j7im0Y8F44TNeU0CKsTM4@easywp.com> u Subject: =?UTF-8?Q?Changes_and_Complementation_in_ICH_Q2(R2)_=E2=80=93_Validation_of_Analytical_Procedures?= , �F�b : From: Website Forms <webmail@metamorphglobal.net> M Message-ID: <VZLQVceO8CGSLjIR1xQVHaZ6SUGr5mQandWIIv5ApDY@easywp.com> u Subject: =?UTF-8?Q?Changes_and_Complementation_in_ICH_Q2(R2)_=E2=80=93_Validation_of_Analytical_Procedures?= ���b M From: Mail Delivery System <Mailer-Daemon@premium80.web-hosting.com> B Message-Id: <E1oDURH-00AcGS-Ow@premium80.web-hosting.com> C Subject: Mail delivery failed: returning message to sender ���b : From: Website Forms <webmail@metamorphglobal.net> M Message-ID: <2il3kDn179Md7jRXLmladb2EHYHaf82CN9MJTm92uPU@easywp.com> R Subject: EU-STATISTICS FOR QUALITY CONTROL AND QUALITY ASSURANCE PRACTICE ( 'g�b : From: Website Forms <webmail@metamorphglobal.net> K Message-ID: <GeVboNYi6KuWp6e6ubqRUOXMGTjAaEI85CwZZiF0U@easywp.com> u Subject: =?UTF-8?Q?Changes_and_Complementation_in_ICH_Q2(R2)_=E2=80=93_Validation_of_Analytical_Procedures?= ��b M From: Mail Delivery System <Mailer-Daemon@premium80.web-hosting.com> B Message-Id: <E1oF85m-00EGuP-Qf@premium80.web-hosting.com> C Subject: Mail delivery failed: returning message to sender ]��b M From: Mail Delivery System <Mailer-Daemon@premium80.web-hosting.com> B Message-Id: <E1oFUxJ-00232E-Nf@premium80.web-hosting.com> C Subject: Mail delivery failed: returning message to sender ��b M From: Mail Delivery System <Mailer-Daemon@premium80.web-hosting.com> B Message-Id: <E1oG22E-002Gdz-9D@premium80.web-hosting.com> C Subject: Mail delivery failed: returning message to sender , ��b : From: Website Forms <webmail@metamorphglobal.net> M Message-ID: <ZdczGakedmQyFtKrCOxlVofOjM81pXL4WomWPKrcFeQ@easywp.com> u Subject: =?UTF-8?Q?Changes_and_Complementation_in_ICH_Q2(R2)_=E2=80=93_Validation_of_Analytical_Procedures?= ( ��b : From: Website Forms <webmail@metamorphglobal.net> K Message-ID: <9bUkvL8i6ntxh6voKoWSyYiow4ZiEG0rC67juY1tE@easywp.com> u Subject: =?UTF-8?Q?Changes_and_Complementation_in_ICH_Q2(R2)_=E2=80=93_Validation_of_Analytical_Procedures?= , ��b : From: Website Forms <webmail@metamorphglobal.net> M Message-ID: <oE8iav1KEVNEnyodaDBOhshfB7uKS0bXn8xYi7bGhkU@easywp.com> v Subject: - US Edition - Contamination Control Strategy Following QRM Principles as Required by EU GMP Annex 1 , ��b : From: Website Forms <webmail@metamorphglobal.net> M Message-ID: <kV3uRY5HsasBzEtxNYu2EoOO7Xh7Ktgh6FvMTwcLZrE@easywp.com> v Subject: - US Edition - Contamination Control Strategy Following QRM Principles as Required by EU GMP Annex 1 ��b M From: Mail Delivery System <Mailer-Daemon@premium80.web-hosting.com> B Message-Id: <E1oIZSA-0022At-Hp@premium80.web-hosting.com> C Subject: Mail delivery failed: returning message to sender , ���b : From: Website Forms <webmail@metamorphglobal.net> M Message-ID: <0WPLJSuh0iD6G64MT5tA2rs0MrHNvqxnPkz8AdZiKho@easywp.com> u Subject: =?UTF-8?Q?Changes_and_Complementation_in_ICH_Q2(R2)_=E2=80=93_Validation_of_Analytical_Procedures?= ( a��b : From: Website Forms <webmail@metamorphglobal.net> K Message-ID: <valpdsIbpI7RweCET16YibHKZ4vzaCtpsJ7rYxUYU@easywp.com> u Subject: =?UTF-8?Q?Changes_and_Complementation_in_ICH_Q2(R2)_=E2=80=93_Validation_of_Analytical_Procedures?= �N�b M From: Mail Delivery System <Mailer-Daemon@premium80.web-hosting.com> B Message-Id: <E1oL70n-008at6-UY@premium80.web-hosting.com> C Subject: Mail delivery failed: returning message to sender ( �,�b : From: Website Forms <webmail@metamorphglobal.net> L Message-ID: <z9nHu9aRZSOlgfJPXnyw1VIIlJEOGCsWhzPGTh6Fwo@easywp.com> u Subject: - EU Edition- Contamination Control Strategy Following QRM Principles as Required by EU GMP Annex 1 , ���b : From: Website Forms <webmail@metamorphglobal.net> M Message-ID: <A5ayUehkXlSFfyf4fngdCPA96e0mPWPWGyEyezw7OLY@easywp.com> v Subject: - US Edition - Contamination Control Strategy Following QRM Principles as Required by EU GMP Annex 1 ( .$�b : From: Website Forms <webmail@metamorphglobal.net> L Message-ID: <AB9AgwOubGsnKITDikXKt0R5WhevvHhgJzDhEAxnBg@easywp.com> v Subject: - US Edition - Contamination Control Strategy Following QRM Principles as Required by EU GMP Annex 1 }��b M From: Mail Delivery System <Mailer-Daemon@premium80.web-hosting.com> B Message-Id: <E1oNeVJ-003i2W-33@premium80.web-hosting.com> C Subject: Mail delivery failed: returning message to sender �K�b : From: Website Forms <webmail@metamorphglobal.net> K Message-ID: <8MjglN771uV0FC43wGx439X1wDEEjcWdzMktZB8ck@easywp.com> R Subject: EU-STATISTICS FOR QUALITY CONTROL AND QUALITY ASSURANCE PRACTICE , ��b : From: Website Forms <webmail@metamorphglobal.net> M Message-ID: <SHerw5FpAhC4oRpqMtTawPe72uC2sldRD6i30jvmFJ4@easywp.com> u Subject: =?UTF-8?Q?Changes_and_Complementation_in_ICH_Q2(R2)_=E2=80=93_Validation_of_Analytical_Procedures?= )�c M From: Mail Delivery System <Mailer-Daemon@premium80.web-hosting.com> B Message-Id: <E1oQBuz-00DqF7-Q6@premium80.web-hosting.com> C Subject: Mail delivery failed: returning message to sender N c M From: Mail Delivery System <Mailer-Daemon@premium80.web-hosting.com> B Message-Id: <E1oSjIU-00D7hM-MZ@premium80.web-hosting.com> C Subject: Mail delivery failed: returning message to sender �c M From: Mail Delivery System <Mailer-Daemon@premium80.web-hosting.com> B Message-Id: <E1oTAWN-000uum-Lq@premium80.web-hosting.com> C Subject: Mail delivery failed: returning message to sender �Ac M From: Mail Delivery System <Mailer-Daemon@premium80.web-hosting.com> B Message-Id: <E1oVGx4-00FEW4-Ns@premium80.web-hosting.com> C Subject: Mail delivery failed: returning message to sender ( ��c : From: Website Forms <webmail@metamorphglobal.net> L Message-ID: <EGmoJoZdYhriB59Ia7cqHEnSaXNNK4yonlhgAKn9RY@easywp.com> u Subject: - EU Edition- Contamination Control Strategy Following QRM Principles as Required by EU GMP Annex 1 �Oc : From: Website Forms <webmail@metamorphglobal.net> M Message-ID: <Bp9fgakvTuPhzNOtNvQswVBtOi5G7GesWUOWm7nrNFw@easywp.com> L Subject: Managerial Aspects of a Generic Pharma Product Development I}c M From: Mail Delivery System <Mailer-Daemon@premium80.web-hosting.com> B Message-Id: <E1oXoMq-002rmQ-Rb@premium80.web-hosting.com> C Subject: Mail delivery failed: returning message to sender � a�!c : From: Website Forms <webmail@metamorphglobal.net> J Message-ID: <m1d6SDsiyQAOALaBRfpew1hwND9bzw102nvvMt1k@easywp.com> J Subject: GCP Quality Systems from an FDA Perspective - US Edition &c M From: Mail Delivery System <Mailer-Daemon@premium80.web-hosting.com> B Message-Id: <E1oZcpr-00AsSR-KS@premium80.web-hosting.com> C Subject: Mail delivery failed: returning message to sender � ��'c = From: Metamorph Global <webmail@metamorphglobal.net> M Message-ID: <kgwYmIIlQ8FnzXjNz0WQYJDrj83ZZIm9MqxIlREzQ44@easywp.com> 3 Subject: WP Mail SMTP Automatic Email Test ��'c M From: Mail Delivery System <Mailer-Daemon@premium80.web-hosting.com> B Message-Id: <E1oa6as-0036u8-Bl@premium80.web-hosting.com> C Subject: Mail delivery failed: returning message to sender ( l�'c = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <4y6ll8r1dxd03EuW5L0InQBHpZGYOUeIEufc0w3nD8@easywp.com> s Subject: Contamination Control Strategy Following QRM Principles as Required by EU GMP Annex 1- EU Edition � ��'c = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <Ebr3Ux0CSwTm4rkOEaoYvvouZe3mosAd9JFyPcMo88@easywp.com> ( Subject: contact form home page �;(c : From: Website Forms <webmail@metamorphglobal.net> M Message-ID: <FQOUO5GpjRD7BYrRQzuzIklEaAyZ7XREfiiIBmhbZDw@easywp.com> L Subject: Managerial Aspects of a Generic Pharma Product Development � >(c : From: Website Forms <webmail@metamorphglobal.net> L Message-ID: <FXwv9tK2TiRjODIC03JMsYX0bjCJh46K1YRmGV6jH0@easywp.com> L Subject: Managerial Aspects of a Generic Pharma Product Development �(c M From: Mail Delivery System <Mailer-Daemon@premium80.web-hosting.com> B Message-Id: <E1oaLmh-00AnGg-Pv@premium80.web-hosting.com> C Subject: Mail delivery failed: returning message to sender � C)c = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <h8sjGaMvXUJL1Rv6SrOl4Tn0xGOUE93mYOsd1O4wfk@easywp.com> 1 Subject: Contact form on metamorphglobal � $C)c = From: Metamorph Global <webmail@metamorphglobal.net> J Message-ID: <iIuXi2gEhI971SmqfADLEdpxeCsUwwTmers5cPC8@easywp.com> ( Subject: contact form home page , JC)c = From: Metamorph Global <webmail@metamorphglobal.net> M Message-ID: <YEqXS6NRUGurP0ZBvVFUIU038oonyXMlMq9ENHHd7Uw@easywp.com> s Subject: Contamination Control Strategy Following QRM Principles as Required by EU GMP Annex 1- EU Edition �C)c = From: Metamorph Global <webmail@metamorphglobal.net> K Message-ID: <bLMZ03HSTOk4IJLH2XfmeULIfcd0YzFOo0XT0ys8I@easywp.com> M Subject: Managerial Aspects of a Generic Pharma Product Development. �C)c = From: Metamorph Global <webmail@metamorphglobal.net> J Message-ID: <HbiEo4GWDO1DsruGtdGcYMLmMvgFkMRCAuaVtHh8@easywp.com> f Subject: How to reduce Risks and Costs in Clinical Trials Using Adaptive Designs - US Edition )D)c = From: Metamorph Global <webmail@metamorphglobal.net> M Message-ID: <tfGqvfydDyxgIy59FSFoM0jlyVgnZxzDLDBB3XUEA9g@easywp.com> f Subject: How to reduce Risks and Costs in Clinical Trials Using Adaptive Designs - US Edition �D)c = From: Metamorph Global <webmail@metamorphglobal.net> M Message-ID: <dAO6zjwM9LLxEMIgMHsKO4F72edyspQj9sXAl4VTJEY@easywp.com> f Subject: How to reduce Risks and Costs in Clinical Trials Using Adaptive Designs - US Edition �D)c = From: Metamorph Global <webmail@metamorphglobal.net> J Message-ID: <MWsDSnEobBmjUFrgW94lD5mD4rInVQM1QUjgBic4@easywp.com> f Subject: How to reduce Risks and Costs in Clinical Trials Using Adaptive Designs - EU Edition � ��)c = From: Metamorph Global <webmail@metamorphglobal.net> K Message-ID: <cnIQzBwXjkHbMvjeW7A0WFzr2evwbZWBmxrLT45bg@easywp.com> 1 Subject: Contact form on metamorphglobal ( �),c = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <IXG5dFmFGTMJjy6B4KJpuLhiNUx83BeNV3iMr3hF6Y@easywp.com> s Subject: Contamination Control Strategy Following QRM Principles as Required by EU GMP Annex 1- EU Edition _^,c = From: Metamorph Global <webmail@metamorphglobal.net> K Message-ID: <Fxmav7lbf6AEKRcQNQPx4XB75Fz7Atv6LhiPi57go@easywp.com> L Subject: Cannabis_Regulations_in_North_America_-_An_Overview-images �^,c = From: Metamorph Global <webmail@metamorphglobal.net> M Message-ID: <Sk50dqbhdrUJXuM6YKCzJmK0UTYnNbRNdJzx8dkg0lY@easywp.com> J Subject: GCP Quality Systems from an FDA Perspective - US Edition �67c = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <Izga0YIaEYSAPjEpFzMizaoCgFDJi3P3G6qaH4k5NM@easywp.com> L Subject: Cannabis_Regulations_in_North_America_-_An_Overview-images �<c M From: Mail Delivery System <Mailer-Daemon@premium80.web-hosting.com> B Message-Id: <E1oftQx-000auT-Jh@premium80.web-hosting.com> C Subject: Mail delivery failed: returning message to sender � �Cc = From: Metamorph Global <webmail@metamorphglobal.net> K Message-ID: <52l1RJ4dADiczTIgZxDTh8yRozdweYDUOXtEtwSm0@easywp.com> B Subject: Smart Process Validation Strategies - US Edition ��Cc = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <dEkYJB8Eh1wBRNpsbMLd23AwAYzSZUmDRuXJIDbAV8@easywp.com> h Subject: Sponsor/Vendor Oversight - US Edition | 15-16 Nov | Dr. rer.nat. Karin Koehler-Hansner ( .�Cc = From: Metamorph Global <webmail@metamorphglobal.net> K Message-ID: <d32RdAFXNxHCwND30L95xD4sLprj1CtngTQTWbwCk@easywp.com> r Subject: Process Scale-Up Course Pharma and Active Ingredients Industry | Nov 21,23 & 28,30 | Jan Harmsen B�Cc = From: Metamorph Global <webmail@metamorphglobal.net> J Message-ID: <JIx1HB0Gys0aLo1ouhw5R71Nl1RcPuUyLcBYUb8Y@easywp.com> Z Subject: Pediatric Drug Development Masterclass | 12-13 December | Dr. Klaus Rose LqDc = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <YDREmkjs3GFM7Iq7H9orwSA61Z2ID4eN87ZdzFtCx0@easywp.com> J Subject: GCP Quality Systems from an FDA Perspective - US Edition � q�Ec = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <fD1HGeGslsCffcheAFvaUBaeAvOlXpMQJ2HiphuRy8@easywp.com> B Subject: Smart Process Validation Strategies - EU Edition � �Ec = From: Metamorph Global <webmail@metamorphglobal.net> M Message-ID: <Qege3YDmqua5cC25xTxYOsyVjjpa86uoSdMS9KOkXOc@easywp.com> B Subject: Smart Process Validation Strategies - EU Edition $ �[ac = From: Metamorph Global <webmail@metamorphglobal.net> J Message-ID: <kAYw6USK3XazwVucSYJ4od06AHzRXL0qdQcLdiQs@easywp.com> o Subject: Changes and Complementation in ICH Q2 (R2) - Validation of Analytical Procedures - US Edition Iec = From: Metamorph Global <webmail@metamorphglobal.net> J Message-ID: <xXNwnSMJQ7Cwhv1oXNXsUqZQdDNisrZO2BoEczLQ@easywp.com> M Subject: Managerial Aspects of a Generic Pharma Product Development. ��fc = From: Metamorph Global <webmail@metamorphglobal.net> K Message-ID: <a8VAEABxfPNFNyuXbUmkOx7Q1KO65sUugFsVFaJe0@easywp.com> h Subject: Sponsor/Vendor Oversight - US Edition | 15-16 Nov | Dr. rer.nat. Karin Koehler-Hansner ( 7lc = From: Metamorph Global <webmail@metamorphglobal.net> M Message-ID: <Uw5aJb9Q2aZ1RAXNZP0BPjdT4ccH32fvZokpmd2iR1k@easywp.com> m Subject: Statistics for Quality Control and Quality Assurance Practice | Dec 6-8 | Dr. Joachim Ermer � �7lc = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <nBQ5BR282QOSSzQzGDVDvaLOFQPtlH52Fqti9WifrM@easywp.com> 8 Subject: REFERENCE STANDARDS IN QUALITY CONTROL � 8lc = From: Metamorph Global <webmail@metamorphglobal.net> J Message-ID: <EpfHLVqHwZczlQKVNKFOFmWRU2xFVxjOiDjhEjBI@easywp.com> 8 Subject: REFERENCE STANDARDS IN QUALITY CONTROL ��lc = From: Metamorph Global <webmail@metamorphglobal.net> J Message-ID: <HeCVQBSSEdnLg6yYmezLj6tSGI0Bkfg04t1C459o@easywp.com> h Subject: Sponsor/Vendor Oversight - US Edition | 15-16 Nov | Dr. rer.nat. Karin Koehler-Hansner ��lc = From: Metamorph Global <webmail@metamorphglobal.net> J Message-ID: <B3hyEv4pU2pSWQ3TvIoVBfvIsAwfZUKoq49QxsdA@easywp.com> h Subject: Sponsor/Vendor Oversight - US Edition | 15-16 Nov | Dr. rer.nat. Karin Koehler-Hansner S mc = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <5lN8qkNpb3A0ppEbPmkrGn21KG6EBvgN1ngTmxU6Qg@easywp.com> Z Subject: Pediatric Drug Development Masterclass | 12-13 December | Dr. Klaus Rose � ��nc = From: Metamorph Global <webmail@metamorphglobal.net> K Message-ID: <mV19qUbgdzmIHW8F8KHaX6X5ELsM7oAxoq6IkvbFY@easywp.com> 8 Subject: REFERENCE STANDARDS IN QUALITY CONTROL , �nc = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <1Hrw04ni8Hk5n70LMvceZGdh0wM4xCuTJZmbXliZek@easywp.com> u Subject: Toxicology to PDE Values, Cleaning Validation and Comprehensive Cross-Contamination Risk Assessment � �oc = From: Metamorph Global <webmail@metamorphglobal.net> M Message-ID: <FDu9q2xGSU1pYOPu2aVBKsSxu1aWJw8FOdiu1vgSD5E@easywp.com> B Subject: Smart Process Validation Strategies - US Edition � ��oc . 1 From: <bryan.shaw@metamorphglobal.io> � 8 Message-ID: <!&!AAAAAAAAAAAuAAAAAAAAAH3TVRjgq9VOtyQWvsfRM/wBAMO2jhD3dRHOtM0AqgC7tuYAAAAAAA4AABAAAABRvzLOB/0iSaApHva2us/oAQAAAAA=@metamorphglobal.io> � 6 Subject: RE: Toxicology to PDE Values, Cleaning Validation and Comprehensive Cross-Contamination Risk Assessment | Reference Standards in Quality Control � ��sc = From: Metamorph Global <webmail@metamorphglobal.net> K Message-ID: <dmx9l2lJLHWWU1XvV90GDUBhKKgtnOnix8JHCT8XA@easywp.com> B Subject: Smart Process Validation Strategies - EU Edition \z~c = From: Metamorph Global <webmail@metamorphglobal.net> K Message-ID: <azpP0YDP2TjtJUlrwQD111xJIenRf31f8UzMeV7TQ@easywp.com> M Subject: Managerial Aspects of a Generic Pharma Product Development. � U)c = From: Metamorph Global <webmail@metamorphglobal.net> K Message-ID: <QmU56mIGBdnw4meGQSX2Qi1M35dzp1OKOJsmxKllA@easywp.com> B Subject: Smart Process Validation Strategies - EU Edition � Q�c = From: Metamorph Global <webmail@metamorphglobal.net> M Message-ID: <ezXCIDHaRky9Og2AVTzd5RM6d7GQFqRf8XzQnwfuVWQ@easywp.com> B Subject: Smart Process Validation Strategies - EU Edition � w�c = From: Metamorph Global <webmail@metamorphglobal.net> K Message-ID: <W6d4ZIrktRQR2bYmZI1iORF2y67z0Wq4GPrcJYeHc@easywp.com> B Subject: Smart Process Validation Strategies - EU Edition � ��c = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <KUapkrAespRraCsdOf7k26fG9QjRhcQ8BWufdr04Bw@easywp.com> B Subject: Smart Process Validation Strategies - US Edition � �\�c = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <AKp2a1TLNEtYfKkZaiGWgoT4MDEtIXS9YZXMgCqTto@easywp.com> B Subject: Smart Process Validation Strategies - US Edition �?�c = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <x91LTrxQw71tfipAl8t1zkxSjwLLxlGcobJqshdpTU@easywp.com> M Subject: Managerial Aspects of a Generic Pharma Product Development. � ox�c = From: Metamorph Global <webmail@metamorphglobal.net> M Message-ID: <JgxnvTjldj4aFB9ZvNzvls3OATjkG6YTMDGz1ROc7B8@easywp.com> 1 Subject: Contact form on metamorphglobal 0ԇc = From: Metamorph Global <webmail@metamorphglobal.net> M Message-ID: <AAsEZ78wtgTBULXDvP6UQEw0Unp4UR1aeDFh599GUu4@easywp.com> Z Subject: Pediatric Drug Development Masterclass | 12-13 December | Dr. Klaus Rose $ ��c = From: Metamorph Global <webmail@metamorphglobal.net> K Message-ID: <2dCdln1P3PvEg2OIr2gPnS6N5iKmRmvW7srqCOXRk@easywp.com> m Subject: Statistics for Quality Control and Quality Assurance Practice | Dec 6-8 | Dr. Joachim Ermer \�c = From: Metamorph Global <webmail@metamorphglobal.net> M Message-ID: <zshey2CRphUf8jgn8oCdzvKRALMbhoOgGpw6MQq2UaY@easywp.com> Z Subject: Pediatric Drug Development Masterclass | 12-13 December | Dr. Klaus Rose $ %��c = From: Metamorph Global <webmail@metamorphglobal.net> K Message-ID: <618om6hPkspfStBlQsPGJbGsfmiFqRHFb8kX7kz70@easywp.com> o Subject: Changes and Complementation in ICH Q2 (R2) - Validation of Analytical Procedures - US Edition ( 栏c = From: Metamorph Global <webmail@metamorphglobal.net> M Message-ID: <2JD67keXyGfCEmIRo8E6yB3kttR1Ol0qU3rGwk55IBg@easywp.com> o Subject: Changes and Complementation in ICH Q2 (R2) - Validation of Analytical Procedures - US Edition $ ���c = From: Metamorph Global <webmail@metamorphglobal.net> K Message-ID: <8nQ23Uk2HWLSPf5KzthbjtEImpMQFiy5F7gcPC78w@easywp.com> o Subject: Changes and Complementation in ICH Q2 (R2) - Validation of Analytical Procedures - US Edition � ��c = From: Metamorph Global <webmail@metamorphglobal.net> K Message-ID: <45qXzMFgdsLO1zAI2jeRdFi3nUgcBa6DeekXyNmzM@easywp.com> 8 Subject: REFERENCE STANDARDS IN QUALITY CONTROL ��c = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <cdz4lanTALupNMnp9dneoAjmwjlgPVfwFujmOV4B6s@easywp.com> Z Subject: Pediatric Drug Development Masterclass | 12-13 December | Dr. Klaus Rose �|�c = From: Metamorph Global <webmail@metamorphglobal.net> M Message-ID: <oEOW3aYNzhVYUDK2qVSf0WDwMVBpsD3T3a9WqS0WdH4@easywp.com> Z Subject: Pediatric Drug Development Masterclass | 12-13 December | Dr. Klaus Rose $ �|�c = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <SKHu1UNJFhI72z9ElAvoqbOxYXbrHsbdunqNSMtMUg@easywp.com> o Subject: Changes and Complementation in ICH Q2 (R2) - Validation of Analytical Procedures - US Edition � z\�c = From: Metamorph Global <webmail@metamorphglobal.net> K Message-ID: <AQiV6tBdW9h1Ux2BazpNnv3CgvtOwQGZwSslsqPHY@easywp.com> 1 Subject: Contact form on metamorphglobal � �Z�c @ From: "Microsoft Outlook" <webmail@metamorphglobal.net> 0 Subject: Microsoft Outlook Test Message � ��c = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <iB3soq1hhCtv69djGU5gBNJI4SofDVDlMkZ929XWtg@easywp.com> ( Subject: contact form home page �3�c = From: Metamorph Global <webmail@metamorphglobal.net> H Message-ID: <l0GNFJg60Ys0JKO6XwUDR49Yv7MthKKyQ9eUMw@easywp.com> l Subject: Assessment of Analytical Performance Across the Lifecycle - EU Edition | Dr. Joachim Ermer G��c M From: Mail Delivery System <Mailer-Daemon@premium80.web-hosting.com> B Message-Id: <E1p6lmB-00EX20-21@premium80.web-hosting.com> C Subject: Mail delivery failed: returning message to sender $ �L�c = From: Metamorph Global <webmail@metamorphglobal.net> K Message-ID: <WSrLmcbY0NSoFSsjgvJYvAa2raOZ3E5ZE1Vz618gA@easywp.com> m Subject: Statistics for Quality Control and Quality Assurance Practice | Dec 6-8 | Dr. Joachim Ermer n�c = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <Foq6lSrBTsf8FIJbDMn3c4hYgdyK7hfmyJXazx5uIE@easywp.com> l Subject: Cleanrooms Qualification And Cleanrooms Monitoring according to the new Annex 1 Requirment ﻲc = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <Vqgtg95CBlgikVR1Xmnc52ZxY5wXM2tbMzq0RlrsfM@easywp.com> l Subject: Cleanrooms Qualification And Cleanrooms Monitoring according to the new Annex 1 Requirment +��c = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <qAO8FsbnFelFJ3j7W6YW2FODUcy3qHheou6cHiXswE@easywp.com> l Subject: Cleanrooms Qualification And Cleanrooms Monitoring according to the new Annex 1 Requirment �òc = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <7jqO4wGGJ8qyiX8TG2NzjdHDREK1DRVDRNastykKRk@easywp.com> l Subject: Assessment of Analytical Performance Across the Lifecycle - EU Edition | Dr. Joachim Ermer Kֲc = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <Izx3T3dEiqfHcwaCFPJmc4A88rN8sFTSlGwJdI6ekw@easywp.com> l Subject: Cleanrooms Qualification And Cleanrooms Monitoring according to the new Annex 1 Requirment $ ��c = From: Metamorph Global <webmail@metamorphglobal.net> M Message-ID: <fOhpU6j05QTPdphC5PB6W6RFYkvpGZjxciTNiohdB7U@easywp.com> l Subject: Cleanrooms Qualification And Cleanrooms Monitoring according to the new Annex 1 Requirment *��c = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <k3tRGz94JWJRhU036WnA4QiHYhQDfcQKrhuT2itlDY@easywp.com> l Subject: Cleanrooms Qualification And Cleanrooms Monitoring according to the new Annex 1 Requirment $ ;�c = From: Metamorph Global <webmail@metamorphglobal.net> M Message-ID: <ZAqonE0jbBWFA8Yb4ukD9gg7UoVIErfUz8WMDlue0sM@easywp.com> l Subject: Cleanrooms Qualification And Cleanrooms Monitoring according to the new Annex 1 Requirment �L�c = From: Metamorph Global <webmail@metamorphglobal.net> J Message-ID: <HL8rjBE19CU3O4wJ8NvRUaXlXTTT2cGfgy9Wn87g@easywp.com> l Subject: Cleanrooms Qualification And Cleanrooms Monitoring according to the new Annex 1 Requirment 7�c = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <PErOeVrtcFKm2HdBG6Ucj9SbpBE1tViTc2herCjjPA@easywp.com> l Subject: Cleanrooms Qualification And Cleanrooms Monitoring according to the new Annex 1 Requirment �;�c = From: Metamorph Global <webmail@metamorphglobal.net> K Message-ID: <NIteuV2E4bcJWSaN9kB7bEadBdhEtgV3L3tqNY1gU@easywp.com> l Subject: Cleanrooms Qualification And Cleanrooms Monitoring according to the new Annex 1 Requirment , ���c = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <dGsuLemaDMSBdQx8bJbkII3mIulQLbp8F7VEgdNJ1A@easywp.com> u Subject: Toxicology to PDE Values, Cleaning Validation and Comprehensive Cross-Contamination Risk Assessment , ��c = From: Metamorph Global <webmail@metamorphglobal.net> I Message-ID: <MtKoldArmxBVV4shMFZ9MUPCwGTRCNjdTHNWTN8@easywp.com> u Subject: Toxicology to PDE Values, Cleaning Validation and Comprehensive Cross-Contamination Risk Assessment $ j�c = From: Metamorph Global <webmail@metamorphglobal.net> M Message-ID: <keUQeRJvusFXoSVbNj6hsLCzHAi1m0ukZKAd8E7572A@easywp.com> l Subject: Cleanrooms Qualification And Cleanrooms Monitoring according to the new Annex 1 Requirment � ��c = From: Metamorph Global <webmail@metamorphglobal.net> K Message-ID: <bubVEAZew3k8b7KWkF5Nj07Iqg6ZTewumeWPUR5vU@easywp.com> 8 Subject: REFERENCE STANDARDS IN QUALITY CONTROL ��c = From: Metamorph Global <webmail@metamorphglobal.net> I Message-ID: <lhyHAFuGNTkBdJa46jTndFMQHeNmlXMK4ZBHjfU@easywp.com> l Subject: Assessment of Analytical Performance Across the Lifecycle - EU Edition | Dr. Joachim Ermer ��c = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <MPrqivW7UvVEKHCS8FV9uXhGQd1DwcvRq9hRlpIL9k@easywp.com> l Subject: Cleanrooms Qualification And Cleanrooms Monitoring according to the new Annex 1 Requirment �c = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <Z9kxik1xTdmp6A3yH07LEn0ImXmhoyRBvB9ENxkOLg@easywp.com> l Subject: Cleanrooms Qualification And Cleanrooms Monitoring according to the new Annex 1 Requirment , ���c = From: Metamorph Global <webmail@metamorphglobal.net> J Message-ID: <DojYiETjGbMR000pRmZSszgPUbm5A8B38VlKCbIw@easywp.com> u Subject: Toxicology to PDE Values, Cleaning Validation and Comprehensive Cross-Contamination Risk Assessment , p��c = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <VjmqIOgYrX85dlPfWfwQLjwEUmrzvjQoB1eZLys5ak@easywp.com> u Subject: Toxicology to PDE Values, Cleaning Validation and Comprehensive Cross-Contamination Risk Assessment � 80�c = From: Metamorph Global <webmail@metamorphglobal.net> K Message-ID: <grlcaI5M4x559BMiFMLcaeZ3R7Sm5Mukye4DfzcqE@easywp.com> 8 Subject: REFERENCE STANDARDS IN QUALITY CONTROL � [0�c = From: Metamorph Global <webmail@metamorphglobal.net> K Message-ID: <W35Za3IoZF8XkdGYKsCLW0nt8Um0aiowCx8xSEV9Q@easywp.com> 8 Subject: REFERENCE STANDARDS IN QUALITY CONTROL , c�c = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <wMLe7pRCwroHLy0ZQFjcLUB07ITLLfqHYLXDegijsQ@easywp.com> u Subject: Toxicology to PDE Values, Cleaning Validation and Comprehensive Cross-Contamination Risk Assessment q��c = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <YaGmoYYg9L9364aTBq0Z0sM6Xz6ldqp9vNYdFa90s8@easywp.com> l Subject: Cleanrooms Qualification And Cleanrooms Monitoring according to the new Annex 1 Requirment , ���c = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <1uOyuIUMjH3L41PJ4oSAuo7CPLb186GIquKGaGjcsU@easywp.com> u Subject: Toxicology to PDE Values, Cleaning Validation and Comprehensive Cross-Contamination Risk Assessment , �v�c = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <H6d4vyU1TvmVofLwZWcqsnxuBMR6Pc31h5my3bkGzI@easywp.com> u Subject: Toxicology to PDE Values, Cleaning Validation and Comprehensive Cross-Contamination Risk Assessment � ���c = From: Metamorph Global <webmail@metamorphglobal.net> K Message-ID: <RyAaHe4WlGN45o4SdoKDm4v5c0UpvX7SMTYsJPn2w@easywp.com> D Subject: Validation & Verification of Analytical Procedures �c = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <2ZgXYBKFTyqyqs0p9izH4MbWPNGRgjIaIPb6N7akQI@easywp.com> ^ Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 � k��c = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <HjkfErG9dmqvzSNk4tgDhcYkkgMO8WdoVVq40ivNpk@easywp.com> , Subject: Analytical Method Transfer , -_�c = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <SlqxwpdyJm9D9G2eE5vkFSAINS6Nxwo6S7pGb8Q6oA@easywp.com> u Subject: Toxicology to PDE Values, Cleaning Validation and Comprehensive Cross-Contamination Risk Assessment , �_�c = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <OuqB6JLBzPtaRMfkZc2NCDH5EAKlJSFNmNaItHdDOU@easywp.com> u Subject: Toxicology to PDE Values, Cleaning Validation and Comprehensive Cross-Contamination Risk Assessment � ���c = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <xlSkpratl10VTMOUPDDjMcHFUU0S5wLtYM0I6MY2xU@easywp.com> ( Subject: contact form home page � ,��c = From: Metamorph Global <webmail@metamorphglobal.net> J Message-ID: <PnclbsORiC3k915i5Ajs4MEeHVFT8HfCwNieJR9g@easywp.com> , Subject: Analytical Method Transfer 0 ���c = From: Metamorph Global <webmail@metamorphglobal.net> M Message-ID: <ATpl6doHhjhA1qtu8deaw7qe6K2mAqDf5BndxDEK1S4@easywp.com> u Subject: Toxicology to PDE Values, Cleaning Validation and Comprehensive Cross-Contamination Risk Assessment , � �c = From: Metamorph Global <webmail@metamorphglobal.net> L Message-ID: <OAPzP6LtJc7gF8G1bMs18a8Q7nzNbktFIjW9kTG70g@easywp.com> u Subject: Toxicology to PDE Values, Cleaning Validation and Comprehensive Cross-Contamination Risk Assessment , @%�c = From: Metamorph Global <webmail@metamorphglobal.net> J Message-ID: <XBUhpIZNlVXJGYsy2ZfReQhFqtizy8LAhtbrCkJI@easywp.com> u Subject: Toxicology to PDE Values, Cleaning Validation and Comprehensive Cross-Contamination Risk Assessment 4 ~��c = From: Metamorph Global <webmail@metamorphglobal.net> S Message-ID: <pIdh2EgEZZKg6L9WpBgsmcDRgbyhOBibihlDypz18@metamorphglobal.io> u Subject: Toxicology to PDE Values, Cleaning Validation and Comprehensive Cross-Contamination Risk Assessment 4 '��c = From: Metamorph Global <webmail@metamorphglobal.net> T Message-ID: <Q7wSPX8e3FO9xPNdIY9iOjRmB3uVviXg82MuG3M6SA@metamorphglobal.io> u Subject: Toxicology to PDE Values, Cleaning Validation and Comprehensive Cross-Contamination Risk Assessment 4 ���c = From: Metamorph Global <webmail@metamorphglobal.net> S Message-ID: <IL0eEGq2XD3UpzO31LIgwkeC1xoUwr0VXSdVuWNYo@metamorphglobal.io> u Subject: Toxicology to PDE Values, Cleaning Validation and Comprehensive Cross-Contamination Risk Assessment 4 ���c = From: Metamorph Global <webmail@metamorphglobal.net> T Message-ID: <QB77ycGuV6oZTSsEE349MfTLmqFlWOL9DhJIafYn9g@metamorphglobal.io> u Subject: Toxicology to PDE Values, Cleaning Validation and Comprehensive Cross-Contamination Risk Assessment 4 Z��c = From: Metamorph Global <webmail@metamorphglobal.net> Q Message-ID: <VbQ575sJmLi8jrDJ1oau4HmHPsNIXofTJfWqXC4@metamorphglobal.io> u Subject: Toxicology to PDE Values, Cleaning Validation and Comprehensive Cross-Contamination Risk Assessment 4 5��c = From: Metamorph Global <webmail@metamorphglobal.net> R Message-ID: <HNva6fBRZIs2x39zzZfuLuLTXkTEWk7ZvgJdYETs@metamorphglobal.io> u Subject: Toxicology to PDE Values, Cleaning Validation and Comprehensive Cross-Contamination Risk Assessment 4 B��c = From: Metamorph Global <webmail@metamorphglobal.net> T Message-ID: <KyuoeC0Nhvkaq8zMJFEMgoYT8ftuNEWfBFTqyiZxjc@metamorphglobal.io> u Subject: Toxicology to PDE Values, Cleaning Validation and Comprehensive Cross-Contamination Risk Assessment � k/�c = From: Metamorph Global <webmail@metamorphglobal.net> S Message-ID: <6IOD5CaGsLSg9pHXDkXV00HThpQli9QX43z2RH5ow@metamorphglobal.io> , Subject: Analytical Method Transfer � ���c = From: Metamorph Global <webmail@metamorphglobal.net> U Message-ID: <LONTxWkATN8ypNzIxiG51IsknDdZj5Js47zFw2DwRaE@metamorphglobal.io> , Subject: Analytical Method Transfer � !��c D - From: Metamorph Global <JessicaWilliams@metamorphglobal.us> R / Message-ID: <PtT4P2qCTpKfgmYEk8T04er3nOnvqyXSieitEvJw@metamorphglobal.io> , . Subject: Analytical Method Transfer � ���c D - From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T / Message-ID: <fKLRw7drPRXmXQd2IqHCgsSh0jsH2zYkauJ5ipvnJE@metamorphglobal.io> , . Subject: Analytical Method Transfer 8 M��c D - From: Metamorph Global <JessicaWilliams@metamorphglobal.us> S / Message-ID: <yjAqHLD8imMqYfFyw8E65mJFl6MgeeTjrUxGElgWs@metamorphglobal.io> u . Subject: Toxicology to PDE Values, Cleaning Validation and Comprehensive Cross-Contamination Risk Assessment , "��c D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 4 Message-ID: <OKTrINTY9MAMut5pZ4KfUFCgSHbmbTAXrq0TeMK76bw@metamorphglobal.io> e 3 Subject: CMC for Cell & Gene Therapy | 12th - 14th July 2023 | Trainer - Dr. Lars J. Branden �c D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> S 4 Message-ID: <xB0zffhJv37hTN0TrYCfz8zUQgFCUHNJoK7tNCz1k@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 ( �G�c D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <iSGpYEnEoDS6X9L2W6Uo1JK5C6GtRa25iZp4hkwOtk@metamorphglobal.io> g 3 Subject: Sand Control Completion Overview | 13th - 14th July 2023 | Trainer - Colter Schroeder � $j�c D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <add5jDAEKVYWYbmEJZUicC68WmPZrTeYgSFPXoPI98@metamorphglobal.io> ( 3 Subject: contact form home page � ���c D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 4 Message-ID: <RhFPSJnk59OTKhn8iQKmViPVYaWrWqIcRIGHplzbUf8@metamorphglobal.io> , 3 Subject: Analytical Method Transfer � ���c D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <4RHG5Y5Cy2IbD4mlAReTDZZan3dH0nHeLw9I6Zwnmg@metamorphglobal.io> , 3 Subject: Analytical Method Transfer � ���c D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> R 4 Message-ID: <4pxTX5JOMcvhJvLekjUm97MDC0LpcFJLNL4BO6zE@metamorphglobal.io> , 3 Subject: Analytical Method Transfer � ��c D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <LdZIz62lNEGudBHRpvdd2MtjnfPm6OollCmNvfmP0U@metamorphglobal.io> , 3 Subject: Analytical Method Transfer � \��c D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> R 4 Message-ID: <HyfWWUX3CFq76dLbJnQo37PjSgFomw9chmkqyyKo@metamorphglobal.io> , 3 Subject: Analytical Method Transfer � ���c D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 4 Message-ID: <9KE4sCnw86byqMju9tponbpqMEpY5rY4vLkhdeIDYt0@metamorphglobal.io> , 3 Subject: Analytical Method Transfer f_�c D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <DKUNfIEXhaeqdI9SpZcuxQVLeIQCwydsr2YVDzwE1c@metamorphglobal.io> D 3 Subject: Validation & Verification of Analytical Procedures � ǘ�c D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <Y5fWpM94sVn2Hvby9OZPTbPTo52lslI6f4oEWgUeq8@metamorphglobal.io> , 3 Subject: Analytical Method Transfer )��c D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <RZpKYcXQictEtIImehYx0Qn383z2gsdfxaLPQCgsjc@metamorphglobal.io> _ 3 Subject: Statistics for Quality Control and Quality Assurance Practice in Europe 2023 � -�c D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 4 Message-ID: <mRfuHzaCU9XqEXSwXVbdCSawY4ifJS8OJAXOikfwfq4@metamorphglobal.io> , 3 Subject: Analytical Method Transfer G�c D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <dB6h0lXCMPfbSuZBBuTeqwbieb2qA1G9afkAuUZQyg@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 $ D��c D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <6AXIOLWPnFAqU0SBHuHmltq0Q4YP8Iywpr2AZCQun8@metamorphglobal.io> c 3 Subject: Stability of chemical substances (small molecules) and products | 20th -21st 2023 ^��c D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 4 Message-ID: <81kZeIdyXuMkvbbvVP1hJTTOAntWfqM0jU60kR18fXI@metamorphglobal.io> D 3 Subject: Validation & Verification of Analytical Procedures ���c D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <NnFmGlB63b7SUkenAv8GeKbDPPxInazAfbM4hs1pno@metamorphglobal.io> D 3 Subject: Validation & Verification of Analytical Procedures ���c D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <ztv7zsG79yvEvHcSJh36PQRKKt4tI4tzD3i8LmYI1Y@metamorphglobal.io> D 3 Subject: Validation & Verification of Analytical Procedures ���c D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <pVPBV9P0U5cOyAcaCHKvKAjQ1nBZwMXzuO1SXoJgO8@metamorphglobal.io> D 3 Subject: Validation & Verification of Analytical Procedures � ���c D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> S 4 Message-ID: <ZUFDcRNsoXYp1kny7OQeQoLtrqxIOw5KFncUcSvyM@metamorphglobal.io> 1 3 Subject: Contact form on metamorphglobal < ���c D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 4 Message-ID: <ydGmEe8VMFTqSV0TrSEUeCLuH2QPKRvFFWEUv2MqHuc@metamorphglobal.io> x 3 Subject: =?UTF-8?Q?Immunogenicity_=E2=80=93_a_challenge_for_complex_therapeutic_|_13th_&_14th_April_2023_|_US?= � �c D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 4 Message-ID: <QyrDJJN5H4ClFKrwB7plVk8C2i9rqm5BRPswrcyzP8g@metamorphglobal.io> J 3 Subject: Reference Standards In Pharmaceutical Analysis in Europe � ƿ�c D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> S 4 Message-ID: <rt7ocqgIDq0CDYS1njYkVl1AZfNS7tOadz6b1zUFA@metamorphglobal.io> / 3 Subject: Intermediate pharmacokinetics 8 ��c D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> R 4 Message-ID: <PGEEhlXlPwdXuVbNjaHGoa2KCuP9Avga3fLcCEwk@metamorphglobal.io> x 3 Subject: =?UTF-8?Q?Immunogenicity_=E2=80=93_a_challenge_for_complex_therapeutic_|_13th_&_14th_April_2023_|_US?= �`�c D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> S 4 Message-ID: <aZaUWwpIoNlNd9RcpKRuXuNf03OsZAITttjcXG2HU@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 � �c D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> S 4 Message-ID: <0lsMdnb5IyimZdBBL4ApmQsqKwUr6xQJKZ6D0RNc0@metamorphglobal.io> , 3 Subject: Analytical Method Transfer j��c D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <hHcMIo80GEsPIOdqV2isKO07vYdJihUd2g3HAN1VsY@metamorphglobal.io> _ 3 Subject: Statistics for Quality Control and Quality Assurance Practice in Europe 2023 � C�c D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <qzJH5TdwLLnI11bzSrVkSDiUIZqUWskN9UP8a9R2Hk@metamorphglobal.io> , 3 Subject: Analytical Method Transfer , =V�c D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> S 4 Message-ID: <yOP5OzjW38pEQxfRTLOU0Ty3Haeq0MzXo8d5QnQAo@metamorphglobal.io> j 3 Subject: Process And Software Validation Overview For Medical Devices | 19th May 2023| Ray Murphy � ά d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> Q 4 Message-ID: <1McEbeOQxtR9GK3hh0QatWtPhXWKGgLUBDwd7kw@metamorphglobal.io> 1 3 Subject: Contact form on metamorphglobal � �Od D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> S 4 Message-ID: <XwJPkIRPVYDGyV5QUUal7Zyt7B5KJvUoqH58H2n0o@metamorphglobal.io> / 3 Subject: Intermediate pharmacokinetics 4 Rd D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <mMbGGZlPb31M4gKWiA8ZnEGuKG4A3FoqP3Y954JNfc@metamorphglobal.io> t 3 Subject: US - How to Reduce Risk And Costs In Clinical Trials Using Adaptive Designs | 27th-28th March 2023 ( &Dd D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 4 Message-ID: <XVjQOEZXPOnHdSENjIHet59CiKKq4rssmUr0LcsZA0o@metamorphglobal.io> c 3 Subject: EU GMP & PICS ANNEX 1 - Navigating the Paradigm Shift in the Regulatory Landscape ( �� d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 4 Message-ID: <m9PmTSooqhVi8gLiNFLkfjkwQkqRbtKMCVP3RwPT4T0@metamorphglobal.io> c 3 Subject: Stability of chemical substances (small molecules) and products | 20th -21st 2023 $ �� d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 4 Message-ID: <xlNZlVp5jFozTu5Sz6diBcHdMVIbAqmnlq4CEjEPWI4@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 0 u� d D 1 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 3 Message-ID: <eVxatG6sN48XULFn30E8caMkTQ8D4sTw1UrzyssNuMM@metamorphglobal.io> l 2 Subject: Cleanrooms Qualification And Cleanrooms Monitoring according to the new Annex 1 Requirment $ � d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> S 4 Message-ID: <Vba7pkQNlMBgMqAPKwEKMil5YfXYFkEQNQSGoaCQM@metamorphglobal.io> c 3 Subject: Stability of chemical substances (small molecules) and products | 20th -21st 2023 '.d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> S 4 Message-ID: <aXQRp648HhKstAAq61gsRuNxQj3FwYR1F0Fi6zn74@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 ��d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> S 4 Message-ID: <MWwfmDLU1fcV1ZrO0XBWCrbLHHMpM2wy38bJqcgPo@metamorphglobal.io> Z 3 Subject: Signal Management in Pharmacovigilance - US Edition | Trainer - Sue Rees ѻd D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <AtKQwFVUniuchQz6wOOth3XEEi024HviL6lDFAoj3A@metamorphglobal.io> Z 3 Subject: Signal Management in Pharmacovigilance - US Edition | Trainer - Sue Rees $ wd D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 4 Message-ID: <ivfKwWg22INuTEN0mzdSiEgRAFeGr3lLDgIGPcQYPXk@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 , B�d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> S 4 Message-ID: <Ko2QCsxwrdG92V4hxSqQTimwvKIBtDEFKabCD9s5E@metamorphglobal.io> j 3 Subject: Water systems in the pharma industry, Isolators Vs RABS systems, Sterile API production $ ><d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 4 Message-ID: <9bFQrFUVoG6T9eGi8hcHYRGuj7gXnahylE6S9zPnqhs@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 � �Vd D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> S 4 Message-ID: <94GcyR7P6EFa9wm2nGgCVmSqZSC0weKwyVK2urUh8@metamorphglobal.io> 1 3 Subject: Contact form on metamorphglobal � gvd D 1 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 3 Message-ID: <RbtVJ5s8ZjGCeHPfiSSdVuG9zsPIzOvAbyqDoMV5t8@metamorphglobal.io> , 2 Subject: Analytical Method Transfer �Td D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> Q 4 Message-ID: <pPhrqLNGihpSGyfZbJJUpnIeTd3AjBPp1hVW1D4@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 $ �Ud D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> S 4 Message-ID: <ug261DsjPUVRVQzpTx09GVDvtvGn7sTCKJwVXEl2o@metamorphglobal.io> c 3 Subject: Stability of chemical substances (small molecules) and products | 20th -21st 2023 ( 7Yd D 1 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 3 Message-ID: <GMG1CBkECpfVLmkljBDvm5VRegbSL3hLK7kp2opCdKQ@metamorphglobal.io> c 2 Subject: Stability of chemical substances (small molecules) and products | 20th -21st 2023 $ �^d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <hSIfyGdylC4QFZzrcTboUE1TThALxCpXN4U3a7oU7M@metamorphglobal.io> c 3 Subject: Stability of chemical substances (small molecules) and products | 20th -21st 2023 ( �ed D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 4 Message-ID: <IVNEeFiBbXgiSp4zeqR4P3oXdNi6IdV4gOV9J0O7IGI@metamorphglobal.io> c 3 Subject: Stability of chemical substances (small molecules) and products | 20th -21st 2023 $ �fd D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> S 4 Message-ID: <R1yaMMpkA2SzdIpKjPW4ulm83YC6CXrJXR7OltF9k@metamorphglobal.io> c 3 Subject: Stability of chemical substances (small molecules) and products | 20th -21st 2023 4 V^d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <6DQNR75aGknF8LscpcBqmYHgdZqWeAmEKvj5HmBrpw@metamorphglobal.io> t 3 Subject: US - How to Reduce Risk And Costs In Clinical Trials Using Adaptive Designs | 27th-28th March 2023 $ �d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <g120QDhIxMdtz6XTVxr4MFCGT2EE84lWzVU7nqboEk@metamorphglobal.io> d 3 Subject: Smart Process Validation Strategies - EU Edition | 13-14 April2023| Dr. Felix Kern $ J�d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <yCcOTCAGR7trIJdobzK1tpqP15OuZSEQ1KOeQMGnt0@metamorphglobal.io> c 3 Subject: Stability of chemical substances (small molecules) and products | 20th -21st 2023 $ ��d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 4 Message-ID: <QxBhrPBpgdy7uP9icjp95yR6zgIbK5dcGPfSGZ3w6WA@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 ( 'd D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 4 Message-ID: <2uLNFVVO2Lk9Tzc7lIF8oPy1FTJAtwQBQvJbIRAm4Ss@metamorphglobal.io> c 3 Subject: EU GMP & PICS ANNEX 1 - Navigating the Paradigm Shift in the Regulatory Landscape $ ,d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> R 4 Message-ID: <KF06n7a3GqdZd118Oj0e11zu9UYsjVfvXIiKSbRc@metamorphglobal.io> c 3 Subject: EU GMP & PICS ANNEX 1 - Navigating the Paradigm Shift in the Regulatory Landscape $ Cd D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <tMhaJBEuohVXAVjzvBvCO6vcuhioWI5AknW8UlaBsc@metamorphglobal.io> c 3 Subject: EU GMP & PICS ANNEX 1 - Navigating the Paradigm Shift in the Regulatory Landscape �d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <vLKLFrvyInFgVVU6w2NV6wbvB705e7bcqpPcapBz4c@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 $ 8�d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <sRPVGCaKhl0dFS0ZVaLRl4jIW0oHejL6Zba6sYn4vQ@metamorphglobal.io> d 3 Subject: Smart Process Validation Strategies - EU Edition | 13-14 April2023| Dr. Felix Kern ��d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 4 Message-ID: <FhecigpS0Ds0E7DInhEuvwToVMyCej2h9Xbu49GfUew@metamorphglobal.io> O 3 Subject: =?UTF-8?Q?Excipients_=E2=80=93_More_than_an_auxiliary_agent?= >/!d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> S 4 Message-ID: <AE6aVzhpv6iVR5FF8LlLkiXDKplBE1t21RxFDtX3c@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 $ 0!d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> R 4 Message-ID: <CROkpnRkfgqOwJCwK8PkJNM0ybVnO1ZfJqNR7TN0@metamorphglobal.io> c 3 Subject: EU GMP & PICS ANNEX 1 - Navigating the Paradigm Shift in the Regulatory Landscape �!d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> R 4 Message-ID: <DikbQPgsHF07WqLhhih4mb7Y0zkRGxKpHxo4QMuQ@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 �"d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> S 4 Message-ID: <kTXP95xcRf8Pe29EqMMhuD98yhCNumIGdl47aFfig@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 ��"d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <Lv0VIkGUyBK8YX7JXWWNy3gwbs8UvFoKi9UnR3gQ9I@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 $ $d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 4 Message-ID: <x97TyzIfNtr1p9LmWifyyAGeHcWdEu2QDF2bYQoN9KA@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 �!$d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <qkPvuPpeNLzmcJwbxjILZZeFM0rrmMnoP6lXKsdVyE@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 %&$d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <Xyp62KZcDFq4z2myFvoW9Wz35hJSBihhyNY9Ba1BAA@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 d&$d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> R 4 Message-ID: <RjlJyYu5gqVSroDTeyngX4kk8F92GEFwkoD6TmOY@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 �&$d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <q3iECOsKEpjm42gqSFhY3p9zCTKGFok9hYFdzn5FZY@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 �'$d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> S 4 Message-ID: <Ht9aZK9FiC0ZAGK1tAbQkpujeZIBC0RaTlvvgu2Uc@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 �($d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> R 4 Message-ID: <HsTtz05ayyQf6keZjxI0KItv8hOdUoG2DUylmTKo@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 $ �($d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 4 Message-ID: <zj9zJuKCqOccEsIxM9hleaHUBAfV7T2UlODki0Vkvtk@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 �($d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <lmyfpAz2UNEg17j0mh4OS9LlUvOCGvojFD7ikXh7Ew@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 � U)$d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <HvUR8cjQgfWwUrUZBRweA2oZgpcU8143A0NpARBFDQ@metamorphglobal.io> ( 3 Subject: contact form home page x)$d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> R 4 Message-ID: <nyvAiGYnjmnVna0JquuC4vxPH9CegIMsxSLeHA9Q@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 �)$d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <CTB3iLvaeGDublqwmtLBUEikr2xjT98mcMTgAIt3hE@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 �)$d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <wg5dNhArAuVQUu003k0zeaL5XLNiE4SI69GqPUBxD4@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 $ �)$d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 4 Message-ID: <z2D8PPm25iPpmnTZhYzar0YMvpzOHha9HuRJhG2xetc@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 T*$d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <gyApeZpV8pLZm2rH5Twz87U3uJZ21bM048K1PSY2b4@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 �+$d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <zVJKhAxTxeHg5jztxGTxENWolYGIZsiH4LaayssAak@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 $ �,$d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 4 Message-ID: <LX8Pb6mizofNGFQdI29sqjzQoBQMur7R2CW6YGuLfv0@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 $ �/$d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 4 Message-ID: <2SOuu7eLQsaUgu2G8kOWqKPaFnNnCWNmB22CrePTpwQ@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 N1$d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <zD7T871F8bGjOPj8MPmryijmaBW3uJxgp8mow1v3kw@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 �1$d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> R 4 Message-ID: <EuCm0qgRfPPWn8XddZJL86PyHyAwroJuTlT7HSx4@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 $ �3$d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 4 Message-ID: <d2eV3sJvS05kN3IDLArlSJdHYg85IEQIbEyWCt437To@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 �7$d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> R 4 Message-ID: <YRwfOdCsQDvTJUJMW4pu1vfGViZlbHPONEeQONMc@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 �;$d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> S 4 Message-ID: <WbgGqoxbeUaw1BSjwwrQUdtMGuslBapJeQz9fHm2U@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 �?$d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> S 4 Message-ID: <K3uNOuIAHUVq4B81OvzWSdF14HXLEb300ns4Odybc@metamorphglobal.io> ^ 3 Subject: Good Manufacturing Practices In EU (GMP) Masterclass | 29th -30th March 2023 $ -z$d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <0SKkJnq41LGJeY1aAyk6R65SCmzzWWekXuewuYwdnI@metamorphglobal.io> c 3 Subject: EU GMP & PICS ANNEX 1 - Navigating the Paradigm Shift in the Regulatory Landscape 4 �o)d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 4 Message-ID: <G1Lmo6T5JDlfPkvSzMZtDHQlxGfAlZ1Js0mnpfHDX3A@metamorphglobal.io> m 3 Subject: Smart Process Validation Strategies US Edition | 21st & 22nd March 2023 | Dr. Felix Tobias $ �p)d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <373jGdQd9YS6DqegJJcNLwPATXNbMiBwk1RafysaZ4@metamorphglobal.io> a 3 Subject: Cell and Gene Therapy Enabling Global CMC Development Exemplified for US and EU $ چ)d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> R 4 Message-ID: <rSUcGyK1T7JsZi76WspSCvOkyKTn5K4eTuqdY5WY@metamorphglobal.io> d 3 Subject: Smart Process Validation Strategies - EU Edition | 13-14 April2023| Dr. Felix Kern ( �`3d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 4 Message-ID: <UFxmDm24vuyHGAlg2XQGHfNOz5cF0wcWximtjJCXkTo@metamorphglobal.io> d 3 Subject: Smart Process Validation Strategies - EU Edition | 13-14 April2023| Dr. Felix Kern � ֞6d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <XyKQBRG77nhY5SFiICVa7dWcU5a8cA4q9XamMLD7rQ@metamorphglobal.io> 1 3 Subject: Contact form on metamorphglobal ( ��Dd D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 4 Message-ID: <26Y08Ly5RWfU6IY5I1DLXpIpEnk6LNGUeVza5F8LZxw@metamorphglobal.io> c 3 Subject: EU GMP & PICS ANNEX 1 - Navigating the Paradigm Shift in the Regulatory Landscape $ ��Dd D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> R 4 Message-ID: <vKHWhGWBgr5zNWGY4z0KWbaynGlRPvAHZQBrml14@metamorphglobal.io> c 3 Subject: EU GMP & PICS ANNEX 1 - Navigating the Paradigm Shift in the Regulatory Landscape $ k�Dd D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> S 4 Message-ID: <TU2khDk31eSVnUdGAdo67UD9ScsDw53cHDs4i5Bz4@metamorphglobal.io> c 3 Subject: EU GMP & PICS ANNEX 1 - Navigating the Paradigm Shift in the Regulatory Landscape $ ��Dd D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> S 4 Message-ID: <Nwff2m1h5QcFtOkAdOCCCZt6K4XIR3txZ0yoQZhfY@metamorphglobal.io> c 3 Subject: EU GMP & PICS ANNEX 1 - Navigating the Paradigm Shift in the Regulatory Landscape ( @oFd D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 4 Message-ID: <jxBsCNxCGVEwiOnFmHoSYOFb9sFDm58CNAsImvQEW8c@metamorphglobal.io> c 3 Subject: EU GMP & PICS ANNEX 1 - Navigating the Paradigm Shift in the Regulatory Landscape ��Fd D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> S 4 Message-ID: <X5cEyIX0EpaoZ0XpfL2KqNq9RrTJC38JVsGTtaLfY@metamorphglobal.io> J 3 Subject: Reference Standards In Pharmaceutical Analysis in Europe < ��Gd D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 4 Message-ID: <BMm1SNvxR2qcG2KSKuWPOGbFix0V401KLkUXGPklKcA@metamorphglobal.io> x 3 Subject: =?UTF-8?Q?Immunogenicity_=E2=80=93_a_challenge_for_complex_therapeutic_|_13th_&_14th_April_2023_|_US?= ( �Jd D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <DGTSh84079cT0S5LfOCS5fYOZosXV9YT6HRxoHqreg@metamorphglobal.io> f 3 Subject: FDA Inspections 101: xFDA Essential Strategies for Success – 28th of June 2023 �Jd D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> S 4 Message-ID: <RcueCQDX1hLbTnH8k1sN3gOiKMKoUur1fzCslJB38@metamorphglobal.io> L 3 Subject: Raw Materials Characterization, Formulation, Stabilization � 3aPd D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <OikjevQ6zZVHhDgTtxcDbsEbKrmPPsUSp7qzYnhZVY@metamorphglobal.io> 1 3 Subject: Contact form on metamorphglobal $ 6�Sd D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <ItlrdZtTAiQrPLMZxil3sDG0XPxi6CYeGbPciZ3gjg@metamorphglobal.io> a 3 Subject: =?UTF-8?Q?EU_Medical_Device_Regulation_for_USA-1_22ND_=E2=80=93_23RD_May_2023?= ��Sd D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <fzJcyidsbyZL4hsO1s6VtdS1uHCuI7WQNqXmxmSazQ@metamorphglobal.io> K 3 Subject: Stability Studies, Especially L&E Studies for Biosimilars � ~bZd D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <D0UFtQw0XQF9MzfO5yJBpYGKbwk9w9ELiUXdcgHCHI@metamorphglobal.io> 3 3 Subject: Bioassays & Bioanalytical Methods $ ��[d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <9TYTH2IupiUHI63VF8PQPfq0CfzjSvyEoIz6dllit0@metamorphglobal.io> a 3 Subject: =?UTF-8?Q?EU_Medical_Device_Regulation_for_USA-1_22ND_=E2=80=93_23RD_May_2023?= 6�\d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <8PYZnOntDIibGIWhyNarfzkSIVJAHQRzSxbCDk2tSM@metamorphglobal.io> J 3 Subject: Reference Standards In Pharmaceutical Analysis in Europe ( �"^d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <gHU7CEvOFHLnlchOWqV1QxVQjZRlCqxpk11IW45azQ@metamorphglobal.io> e 3 Subject: CMC for Cell & Gene Therapy | 12th - 14th July 2023 | Trainer - Dr. Lars J. Branden m�^d D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> S 4 Message-ID: <rQTavkC5gYX8F6lOTQma3kZIkgdEcvKH3kr8FNvyk@metamorphglobal.io> J 3 Subject: Reference Standards In Pharmaceutical Analysis in Europe � <�gd D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <SJxr8M359J1jvCCGV6Yo8fSEbfLsMxAMfC1VxaxuF4@metamorphglobal.io> 1 3 Subject: Contact form on metamorphglobal �kd D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> Q 4 Message-ID: <89OEw4FPqhy5r1DMIcYnVXi2hDC9JXBMK2r6qFY@metamorphglobal.io> _ 3 Subject: Data Intergrity In CMC | 27th-28th April 2023 | Trainer Prof. Dr. Markus Veit � �gld D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> S 4 Message-ID: <BCpQQcvAiBYvJrcR4DWXmWuRzb4ExYPPxPCp0wZ9U@metamorphglobal.io> 3 3 Subject: Bioassays & Bioanalytical Methods -�ld D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 4 Message-ID: <hKt3WWsOKX15iBfjrnHNquEhtVuSukjKD2LSdg8QGgg@metamorphglobal.io> N 3 Subject: Mastering Good Clinical Practice For Pharma Professionals 23 $ m�ld D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 4 Message-ID: <ZgdDOoVrBUrRTbs5tl9wGukwgkUC7emDi3wAZKMvh50@metamorphglobal.io> _ 3 Subject: Global CMC Development in Cell & Gene Therapy (Eu) Date :17th -19th July 2023 @ ��ld D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <XrrIvIiTvPHqxkvI3hwTJ1ipgWTWxacDDKObvXADMg@metamorphglobal.io> } 3 Subject: Navigating Regulatory Challenges in CMC Development for New Biological Entities Date : 29TH -30th June 2023 � �ld D 2 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 4 Message-ID: <OlHeXHtAkLktjZjchi5HI73URejWqUDwZLPSEAXSSk@metamorphglobal.io> 1 3 Subject: Contact form on metamorphglobal 8 ���d D 5 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> U 7 Message-ID: <8kH3B1L0VtJDeGpgmtiBpcooimO1yLIE9ZqFDmDqmu4@metamorphglobal.io> r 6 Subject: Annex 1 GMP Compliance following the effective date (2nd Edition) Date : 6th -8th September 2023 ٨�d D 5 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> T 7 Message-ID: <et23mne5u6E1sag802FLab6D5Yg64YcnMZd04Fq9g4@metamorphglobal.io> H 6 Subject: Real Estate: FDA Inspection 101 Date : 20th July 2023 ( ꨯd D 5 From: Metamorph Global <JessicaWilliams@metamorphglobal.us> S 7 Message-ID: <tfPzl0Wz99dTnEqk7178C8rBqmsdvT8T9eW5mn0sw@metamorphglobal.io> e 6 Subject: CMC for Cell & Gene Therapy | 12th - 14th July 2023 | Trainer - Dr. Lars J. Branden 4 ���d = From: Metamorph Global <webmail@metamorphglobal.net> U Message-ID: <mKtFnFqI9Yyuq2x4QvYXd8nO9rL4xqmTfNW9HsU5RFM@metamorphglobal.io> r Subject: Annex 1 GMP Compliance following the effective date (2nd Edition) Date : 6th -8th September 2023 ԩ�d = From: Metamorph Global <webmail@metamorphglobal.net> S Message-ID: <HxI8Ja60n5iaYzeo5W4CwMU60OlkIUBo0CUpFJt4U@metamorphglobal.io> C Subject: Gas Chromatography in the Oil and Gas Industry 23 0 -�d = From: Metamorph Global <webmail@metamorphglobal.net> T Message-ID: <8w2z61U5p7dcyOBH5TxFsO2Wa8kdCGhrbN76ykyzWg@metamorphglobal.io> r Subject: Annex 1 GMP Compliance following the effective date (2nd Edition) Date : 6th -8th September 2023 0 y�d = From: Metamorph Global <webmail@metamorphglobal.net> T Message-ID: <BLPO3663w9TZh89NRBEf2AL4zDs2oAXIiKJ06PTBdI@metamorphglobal.io> r Subject: Annex 1 GMP Compliance following the effective date (2nd Edition) Date : 6th -8th September 2023 , sѷd = From: Metamorph Global <webmail@metamorphglobal.net> U Message-ID: <1uL7aU1yReZ3xlHwmHLgRODzj76iTMIaHy7dd6RnZuA@metamorphglobal.io> l Subject: =?UTF-8?Q?Writing_Highly_Effective_Audit_Reports_Date_:13th_=E2=80=93_14th_November_2023?= �ѷd = From: Metamorph Global <webmail@metamorphglobal.net> R Message-ID: <q2FXz6VttHuITbZvdScVlgKMGRS2F4MkrxpTvkGk@metamorphglobal.io> G Subject: Auditing Major Projects Date :29th-30th November 2023 � ^L�d = From: Metamorph Global <webmail@metamorphglobal.net> T Message-ID: <k0ZTsqddc251sAAXlEE60jEAJdC6fJhj7U2BgpeNQU@metamorphglobal.io> 1 Subject: Contact form on metamorphglobal � �L�d = From: Metamorph Global <webmail@metamorphglobal.net> S Message-ID: <TUbhXYXUxKzjefbJMUl5qNerDHwz3CVzq56KoAuyA@metamorphglobal.io> 1 Subject: Contact form on metamorphglobal � Uþd = From: Metamorph Global <webmail@metamorphglobal.net> R Message-ID: <YQwrsgX7eqRKx7HLtLb9XGCJGt0IguDnfx327Mk0@metamorphglobal.io> ( Subject: contact form home page 0 �Q�d = From: Metamorph Global <webmail@metamorphglobal.net> R Message-ID: <ORKZonfqw5WiO9GmL21e2GoRYvf0cTMddVuTLVq4@metamorphglobal.io> r Subject: Annex 1 GMP Compliance following the effective date (2nd Edition) Date : 6th -8th September 2023 � �e = From: Metamorph Global <webmail@metamorphglobal.net> U Message-ID: <WagFUmdvrTcD4XXXYkr3334G4fPTe0o24AFx1RILGm4@metamorphglobal.io> ; Subject: Succession Planning and Talent Management � �He @ From: "Microsoft Outlook" <webmail@metamorphglobal.net> 0 Subject: Microsoft Outlook Test Message $ ��e = From: Metamorph Global <webmail@metamorphglobal.net> T Message-ID: <Y08Quj9Mqef0Jr2Q50qfFrMoSwT4BRTSiv3iozXVlA@metamorphglobal.io> e Subject: | Mastering CMC Compliance: Crafting Comprehensive Technical Documents for NDAs/MAA $ ̹e = From: Metamorph Global <webmail@metamorphglobal.net> T Message-ID: <WaIxAH2gaQMnf8Y0axqwxN7UEa0fMAXHCeXMg5LQLY@metamorphglobal.io> e Subject: | Mastering CMC Compliance: Crafting Comprehensive Technical Documents for NDAs/MAA 0 �ge = From: Metamorph Global <webmail@metamorphglobal.net> T Message-ID: <JgdkyNb0wxjNCqymfUGDv8LdpBqFHO82WMjPkrUG8o@metamorphglobal.io> r Subject: Mastering Particle Size Characterization-Integrating Laboratory Excellence With Business Success , *#e = From: Metamorph Global <webmail@metamorphglobal.net> U Message-ID: <VCiLPHj6N66KYvQSn2SoggC8jpqBuejWgArkwlDaWFk@metamorphglobal.io> j Subject: Navigating the New Tax Landscape: Demystifying UAE's Latest Regulations for Corporations ( Qge = From: Metamorph Global <webmail@metamorphglobal.net> T Message-ID: <xPLA6MKqdDqH6TLaVc8arnp4sUcp1YJAzIp6adTq6I@metamorphglobal.io> j Subject: Navigating the New Tax Landscape: Demystifying UAE's Latest Regulations for Corporations � �ge = From: Metamorph Global <webmail@metamorphglobal.net> T Message-ID: <0XPdeDUiaI6lDEIx4yzM0gWveKyp4YTZvHXA4peF78@metamorphglobal.io> ; Subject: Succession Planning and Talent Management $ ve = From: Metamorph Global <webmail@metamorphglobal.net> S Message-ID: <i5CBPNokuDlG2CHHpDNBat7o2d4CqHAKxGAj6v3qI@metamorphglobal.io> e Subject: | Mastering CMC Compliance: Crafting Comprehensive Technical Documents for NDAs/MAA � �/e = From: Metamorph Global <webmail@metamorphglobal.net> T Message-ID: <9xNjV2qs6hQvy6w5hJtFVwpAcZUSBWJwEMBRzBcP2s@metamorphglobal.io> 1 Subject: Contact form on metamorphglobal � ��e = From: Metamorph Global <webmail@metamorphglobal.net> T Message-ID: <SKyEPGbGvspFnH70zelwWmY088c71C3gIJ7AeRhxNc@metamorphglobal.io> ? Subject: Statistical Methods for Process Validation US � ��e = From: Metamorph Global <webmail@metamorphglobal.net> Q Message-ID: <NzKFY8apeTbaCEQl47QdR91cNvGmiI4iRXcViNc@metamorphglobal.io> ? Subject: Statistical Methods for Process Validation US 0 ��e = From: Metamorph Global <webmail@metamorphglobal.net> S Message-ID: <3YnZLJdR4KlTMMTVIkU4GxBRYOavPXwP1wMLLtFV4@metamorphglobal.io> s Subject: Annex 1 GMP Compliance following the effective date (3rd Edition) Date : 11th -14th December 2023 � �d%e = From: Metamorph Global <webmail@metamorphglobal.net> T Message-ID: <J8GyQwtuBldIWqb8nZRA40zOElTaNwkA3ahirMyXo8@metamorphglobal.io> 7 Subject: Strategic Marketing For CDMO Industry �(&e = From: Metamorph Global <webmail@metamorphglobal.net> U Message-ID: <8EtaLYqwO29G4CpnqSukQuD23EKUiXVaHhX6XvlApmc@metamorphglobal.io> D Subject: GMP Auditing, Inspections & Supplier Qualification i(e = From: Metamorph Global <webmail@metamorphglobal.net> U Message-ID: <thwhbveSYZcBDWViPlXvCimpJKwtquMAbWgAHuZELjU@metamorphglobal.io> ? Subject: Statistical Methods for Process Validation US � i(e = From: Metamorph Global <webmail@metamorphglobal.net> S Message-ID: <HyXxrrYuBwwod2nAJpQ2KhZpzWZGu7d8uju8tqQ8w@metamorphglobal.io> ? Subject: Statistical Methods for Process Validation US �7-e = From: Metamorph Global <webmail@metamorphglobal.net> R Message-ID: <zFR8EzE1VilHReFxarLoNVooNF0UxT05nH2w6ego@metamorphglobal.io> D Subject: GMP Auditing, Inspections & Supplier Qualification Ej/e = From: Metamorph Global <webmail@metamorphglobal.net> U Message-ID: <5K4ITORNKwe17xyHkx9UEUlaa11goj0EZ2JAkfMn2NM@metamorphglobal.io> D Subject: GMP Auditing, Inspections & Supplier Qualification l�/e = From: Metamorph Global <webmail@metamorphglobal.net> S Message-ID: <qBYWUuscPiId01mOz6QcHiZhPoaxsHVbjwZkzsuhA@metamorphglobal.io> D Subject: GMP Auditing, Inspections & Supplier Qualification � �_2e = From: Metamorph Global <webmail@metamorphglobal.net> T Message-ID: <7kYc1htRs72RaNd18LGzmCmiJpbKcTmrzSOlemPxuE@metamorphglobal.io> ? Subject: Statistical Methods for Process Validation US � l&6e = From: Metamorph Global <webmail@metamorphglobal.net> S Message-ID: <KWWntNu8xTDYhzG5i4QfP8YyPdH08YfKHbpmoqJS8@metamorphglobal.io> ? Subject: Statistical Methods for Process Validation US �(6e = From: Metamorph Global <webmail@metamorphglobal.net> T Message-ID: <vOpXHy7XA3MRmbLzBh8uCAoi8cVJPlenohPHeEsJ84@metamorphglobal.io> D Subject: GMP Auditing, Inspections & Supplier Qualification �+6e = From: Metamorph Global <webmail@metamorphglobal.net> S Message-ID: <wgUMZbHQrYPSs0ErNKHKxLpjj6NXZBQ4ojurLotUg@metamorphglobal.io> D Subject: GMP Auditing, Inspections & Supplier Qualification 4 g�6e = From: Metamorph Global <webmail@metamorphglobal.net> U Message-ID: <4PkhNCXJTjjPn2ZiSdQWgxcmKxkGhA4J1EASyJQ2Mss@metamorphglobal.io> r Subject: Mastering Particle Size Characterization-Integrating Laboratory Excellence With Business Success ��6e = From: Metamorph Global <webmail@metamorphglobal.net> U Message-ID: <NQ673tzP7VSkmRyZpkw8Nh0swSREGnnaKqD4hxxyYc4@metamorphglobal.io> ? Subject: Statistical Methods for Process Validation US � ��7e = From: Metamorph Global <webmail@metamorphglobal.net> T Message-ID: <fCbFFpvVxjyW4jz9sg2qWCqelgIjb1dcUhwvYeqHJA@metamorphglobal.io> 1 Subject: Contact form on metamorphglobal ��7e M From: Mail Delivery System <Mailer-Daemon@premium80.web-hosting.com> B Message-Id: <E1qvICD-00H0nW-0o@premium80.web-hosting.com> C Subject: Mail delivery failed: returning message to sender WL8e = From: Metamorph Global <webmail@metamorphglobal.net> U Message-ID: <xlSMA7NXMiKxyl1MrvixUeMvfPmyXoTTevBbjkQVA4U@metamorphglobal.io> ? Subject: Statistical Methods for Process Validation US 0 I�8e = From: Metamorph Global <webmail@metamorphglobal.net> R Message-ID: <JdX10vvgCYqR0YnQDOgWYhmeoNGkuqxnTuJJ3340@metamorphglobal.io> r Subject: Mastering Particle Size Characterization-Integrating Laboratory Excellence With Business Success � �J:e = From: Metamorph Global <webmail@metamorphglobal.net> T Message-ID: <Z7ML2y6UPq0E0pRznND4iGrKKeh50YkCl98PkEg8hs@metamorphglobal.io> ; Subject: Succession Planning and Talent Management � /\:e = From: Metamorph Global <webmail@metamorphglobal.net> R Message-ID: <cJiuu5moDdUSYOsPyId11iWnJPZVd4UeD4R5P1Z8@metamorphglobal.io> ; Subject: Succession Planning and Talent Management ��<e M From: Mail Delivery System <Mailer-Daemon@premium80.web-hosting.com> B Message-Id: <E1qwfma-00EmSa-0W@premium80.web-hosting.com> C Subject: Mail delivery failed: returning message to sender 9�=e = From: Metamorph Global <webmail@metamorphglobal.net> U Message-ID: <5k1lbeBwp1rM9GDzlFh8loA9jfmcA9xOdMT9gxhjbxQ@metamorphglobal.io> ? Subject: Statistical Methods for Process Validation US ��@e M From: Mail Delivery System <Mailer-Daemon@premium80.web-hosting.com> B Message-Id: <E1qxlBl-009ODS-1O@premium80.web-hosting.com> C Subject: Mail delivery failed: returning message to sender 4 �'Ae = From: Metamorph Global <webmail@metamorphglobal.net> S Message-ID: <9CVxPnRFiyHdz0zHdwfepv9PZtgsPxKzo4eZoYn3Q@metamorphglobal.io> u Subject: Toxicology to PDE Values, Cleaning Validation and Comprehensive Cross-Contamination Risk Assessment � v-Be = From: Metamorph Global <webmail@metamorphglobal.net> T Message-ID: <rAZvNfAKZfY3k8YKoTotAVDtAnO0Hh6b473nGRy41I@metamorphglobal.io> 1 Subject: Contact form on metamorphglobal 0 {�He = From: Metamorph Global <webmail@metamorphglobal.net> R Message-ID: <2MgeT8QWbN6lk9dD2FGO60tIAIKJeZ32jomr8DlU@metamorphglobal.io> r Subject: Mastering Particle Size Characterization-Integrating Laboratory Excellence With Business Success � �\Re = From: Metamorph Global <webmail@metamorphglobal.net> S Message-ID: <zF27BrFU6Z8d4LkVZBQ1olQfsE88jpgRwY7xh24N4@metamorphglobal.io> ? Subject: Statistical Methods for Process Validation US � z�Ue = From: Metamorph Global <webmail@metamorphglobal.net> T Message-ID: <Astn3qV7xsV95DiAQQ7kxhQhxzULwwpco1ZTUQePRs@metamorphglobal.io> ? Subject: Statistical Methods for Process Validation US g�Ve = From: Metamorph Global <webmail@metamorphglobal.net> S Message-ID: <aTxfDh8wvwVBqfaMv0l4rdDukmXAZKSygkkpAht9c@metamorphglobal.io> \ Subject: Pharmaceutical Innovations in Fundamental Analysis and Reverse Engineering � �4[e = From: Metamorph Global <webmail@metamorphglobal.net> T Message-ID: <fTHo0lVB7Pj8JR7roAmrR2AgRbY5gvLKS8sVFkHs60@metamorphglobal.io> 1 Subject: Contact form on metamorphglobal ��he M From: Mail Delivery System <Mailer-Daemon@premium80.web-hosting.com> B Message-Id: <E1r8mL9-0094Qf-0h@premium80.web-hosting.com> C Subject: Mail delivery failed: returning message to sender � ��he <